Uveitis complicated by phthisis bulbi: hemodynamic parameters in the prediction of anterior-posterior eye size reduction
PDF

Keywords

infectious uveitis
noninfectious uveitis
phthisis bulbi hemodynamic disorders
anterior-posterior size of the eyeball

How to Cite

Panchenko, M., Khramova, T., Pavlyuchenko, O., Muzhychuk, O., Honchar, O., Panchenko, H., & Kitchenko, I. (2024). Uveitis complicated by phthisis bulbi: hemodynamic parameters in the prediction of anterior-posterior eye size reduction. Inter Collegas, 11(1), 27-32. https://doi.org/10.35339/ic.11.1.pkp

Abstract

Background. Phthisis bulbi is a serious complication of uveitis, causing vision loss and esthetic defects. Hemodynamic disorders can play an important role in the formation of this complication as a result of uveitis. We did not find data on predicting the progression of phthisis bulbi with a reduction in anterior-posterior size in the available literature.

Aim. To analyze the possibility of predicting the reduction in the anterior-posterior size of the eye with uveitis, complicated by phthisis bulbi, based on hemodynamic parameters

Materials and Methods. 33 patients aged 5–84 years, of them 19 male and 14 female patients, with unilateral endogenous uveitis, complicated by phthisis bulbi, were examined. 15 patients with uveitis complicated by phthisis bulbi, who had not received any treatment during this time, were examined in dynamics (for at least 1 year). All patients underwent Doppler ultrasound examination of the ophthalmic artery and short posterior ciliary arteries. In addition, all patients underwent biomicroscopic and tonometric examinations, ultrasound biomicroscopy, rheoophthalmography of eyeballs, A-scan and B-scan ultrasonography. The results of the examination of eyes with uveitis complicated by phthisis bulbi were compared with the results of the examination of paired (healthy) eyes of the same patients.

Results. We have developed a multiple regression model that allows us to predict a reduction in the anterior-posterior size of the eye with phthisis bulbi due to uveitis. The dynamics of the disease in 15 patients not taking any treatment for uveitis, has been monitored for more than a year. The prediction of phthisis bulbi progression was confirmed in 13 patients, which amounts to 86.7% (p<0.05).

Conclusions. We have proposed a model that allows predicting the progressive or stationary course of phthisis bulbi due to uveitis based on hemodynamic parameters.

Keywords: infectious uveitis, noninfectious uveitis, phthisis bulbi hemodynamic disorders, anterior-posterior size of the eyeball.

https://doi.org/10.35339/ic.11.1.pkp
PDF

References

Maria DM, Ulrike K, Gerhild W. The immunopathogenesis of chronic and relapsing autoimmune uveitis - Lessons from experimental rat models. Prog Retin Eye Res. 2018;65:107-26. DOI: 10.1016/j.preteyeres.2018.02.003. PMID: 29496590.

Barros Ferreira L, Ashander LM, Ma Y, Appukuttan B, Williams KA, Best G, Smith JR. Effects of tumor necrosis factor-α and interleukin-1β on human retinal endothelial cells. Cytokine. 2024;173:156407. DOI: 10.1016/j.cyto.2023.156407. PMID: 37924741.

Panchenko NV, Samofalova MN, Gonchar EN, Prykhodko DO, Arustamova GS, Lytvyshchenko AV. Alterations in the expression of tumor necrosis factor-alpha in the uveitis with optic nerve inflammation. J. ophthalmol. (Ukraine). 2016;(5):18-21. DOI: 10.31288/oftalmolzh201651821.

Wu X, Tao M, Zhu L, Zhang T, Zhang M. Pathogenesis and current therapies for non-infectious uveitis. Clin Exp Med. 2023;23(4):1089-106. DOI: 10.1007/s10238-022-00954-6. PMID: 36422739.

Zhang T, Han X, Zhong Y, Kam HT, Qiao D, Chen Z, et al. Regulatory T cell intravitreal delivery using hyaluronan methylcellulose hydrogel improves therapeutic efficacy in experimental autoimmune uveitis. Biomater Adv. 2023;151:213496. DOI: 10.1016/j.bioadv.2023.213496. PMID: 37290283.

Choi JK, Egwuagu CE. Analysis of Regulatory B Cells in Experimental Autoimmune Uveitis. Methods Mol Biol. 2021;2270:437-50. DOI: 10.1007/978-1-0716-1237-8_23. PMID: 33479912.

Panchenko NV, Samofalova MN, Friantseva MV. Anti-inflammatory cytokines content in different clinical uveitis course complicated by the optic nerve inflammation. J. ophthalmol. (Ukraine). 2016;(1):24-6 DOI: 10.31288/oftalmolzh201612426.

Ferrara M, Eggenschwiler L, Stephenson A, Montieth A, Nakhoul N, Araujo-Miranda R, Foster CS. The Challenge of Pediatric Uveitis: Tertiary Referral Center Experience in the United States. Ocul Immunol Inflamm. 2019;27(3):410-7. DOI: 10.1080/09273948.2017.1420202. PMID: 29333911.

Kramer M, Brichova M, Tugal-Tutkun I, Panchenko M, Gormezano N, Koenigsbauer F, et al; International EyeCOPE Study Group. Noninfectious Intermediate, Posterior, or Panuveitis: Results from the Retrospective, Observational, International EyeCOPE Study. Ophthalmol Ther. 2021;10(3):565-80. DOI: 10.1007/s40123-021-00351-4. PMID: 34117983.

Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. 2004;111(12):2299-306. DOI: 10.1016/j.ophtha.2004.06.014. PMID: 15582090.

Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K; German Uveitis in Childhood Study Group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford). 2007;46(6):1015-9. DOI: 10.1093/rheumatology/kem053. PMID: 17403710.

Abu Samra K, Maghsoudlou A, Roohipoor R, Valdes-Navarro M, Lee S, Foster CS. Current Treatment Modalities of JIA-associated Uveitis and its Complications: Literature Review. Ocul Immunol Inflamm. 2016;24(4):431-9. DOI: 10.3109/09273948.2015.1115878. PMID: 26765345.

Woreta F, Thorne JE, Jabs DA, Kedhar SR, Dunn JP. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2007;143(4):647-55. DOI: 10.1016/j.ajo.2006.11.025. PMID: 17224116.

Adewara BA, Badmus SA, Olugbade OT, Ezeanosike E, Adegbehingbe BO. Distribution of phthisis bulbi and status of fellow eyes at a tertiary eye-care centre in Nigeria: a ten-year review. Afr Health Sci. 2021;21(1):437-44. DOI: 10.4314/ahs.v21i1.54. PMID: 34394326.

Tan LT, Isa H, Lightman S, Taylor SR. Prevalence and causes of phthisis bulbi in a uveitis clinic. Acta Ophthalmol. 2012;90(5):e417-8. DOI: 10.1111/j.1755-3768.2011.02319.x. PMID: 22176695.

Karahan M, Demirtas AA. Causes of Blindness in Adults in Southern Turkey According to Health Committee Reports. Turk J Ophthalmol. 2021;51(3):146-50. DOI: 10.4274/tjo.galenos.2020.76301. PMID: 34187147.

Negrel AD, Minassian DC, Sayek F. Blindness and low vision in southeast Turkey. Ophthalmic Epidemiol. 1996;3(3):127-34. DOI: 10.3109/09286589609080118. PMID: 8956316.

Njuguna M, Msukwa G, Shilio B, Tumwesigye C, Courtright P, Lewallen S. Causes of severe visual impairment and blindness in children in schools for the blind in eastern Africa: changes in the last 14 years. Ophthalmic Epidemiol. 2009;16(3):151-5. DOI: 10.1080/09286580902738183. PMID: 19437309.

Huh GJ, Simon J, Grace Prakalapakorn S. Causes of childhood blindness in Ghana: results from a blind school survey in Upper West Region, Ghana, and review of the literature. Int Ophthalmol. 2018;38(4):1415-23. DOI: 10.1007/s10792-017-0600-9. PMID: 28612329.

Kello AB, Gilbert C. Causes of severe visual impairment and blindness in children in schools for the blind in Ethiopia. Br J Ophthalmol. 2003;87(5):526-30. DOI: 10.1136/bjo.87.5.526. PMID: 12714383.

Kitzmann AS, Weaver AL, Lohse CM, Buettner H, Salomao DR. Clinicopathologic correlations in 646 consecutive surgical eye specimens, 1990–2000. Am J Clin Pathol. 2003;119(4):594-601. DOI: 10.1309/MLRM-QWAF-V6A1-15UA. PMID: 12710132.

de Gottrau P, Holbach LM, Naumann GO. Clinicopathological review of 1146 enucleations (1980–90). Br J Ophthalmol. 1994;78(4):260-5. DOI: 10.1136/bjo.78.4.260. PMID: 8199109.

Dave TV, Das AV, Mohapatra S, Bansal O, Ganguly A. Demography, Clinical Settings and Outcomes in Evisceration with Implant: An Electronic Medical Records Driven Analytics of 2071 Cases. Semin Ophthalmol. 2023;38(4):344-51. DOI: 10.1080/08820538.2022.2085519. PMID: 35675109.

Farokhfar A, Ahmadzadeh-Amiri A, Sheikhrezaee MR, Gorji MAH, Agaei N. Common Causes of Eye Enucleation among Patients. J Nat Sci Biol Med. 2017;8(2):150-3. DOI: 10.4103/0976-9668.210006. PMID: 28781478.

Coskun M, Atas M, Akal A, Ilhan O, Keskin U, Tuzcu EA. Delici göz küresi yaralanmalarından sonra fitizis bulbi gelişiminde etkili olan faktörler [The factors affecting the development of phthisis bulbi after penetrating eye injuries]. Ulus Travma Acil Cerrahi Derg. 2012;18(4):317-20. DOI: 10.5505/tjtes.2012.02223. PMID: 23138998. [In Turkish].

Santamaria A, Perez S, De Luis B, Orive A, Feijoo R, Etxebarria J. Clinical characteristics and prognostic factors of open globe injuries in a North Spain population: a 10-year review. Eye (Lond). 2023;37(10):2101-8. DOI: 10.1038/s41433-022-02297-8. PMID: 36371603.

Toth G, Pluzsik MT, Csakany B, Sandor GL, Lukats O, Nagy ZZ, Szentmary N. Clinical Review of Ocular Traumas Resulting in Enucleation or Evisceration in a Tertiary Eye Care Center in Hungary. J Ophthalmol. 2021;2021:5588977. DOI: 10.1155/2021/5588977. PMID: 34136279.

Kaliki S, Jajapuram SD, Bejjanki KM, Ramappa G, Mohamed A, Mishra DK. Enucleation in Asian Indian patients: a histopathological review of 2009 cases. Eye (Lond). 2019;33(1):120-8. DOI: 10.1038/s41433-018-0226-9. PMID: 30315260.

Tripathy K, Chawla R, Temkar S, Sagar P, Kashyap S, Pushker N, Sharma YR. Phthisis Bulbi-a Clinicopathological Perspective. Semin Ophthalmol. 2018;33(6):788-803. DOI: 10.1080/08820538.2018.1477966. PMID: 29902388

Si S, Su W, Wang L, Ji Y, Chen A, Hu Y. A novel predictive model for phthisis bulbi following facial hyaluronic acid cosmetic injection. BMC Ophthalmol. 2023;23(1):244. DOI: 10.1186/s12886-023-02992-4. PMID: 37259051.

Pineles SL, Chang MY, Oltra EL, Pihlblad MS, Davila-Gonzalez JP, Sauer TC, Velez FG. Anterior segment ischemia: etiology, assessment, and management. Eye (Lond). 2018;32(2):173-178. DOI: 10.1038/eye.2017.248. PMID: 29148529.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.